Clinical Trials Directory

Trials / Completed

CompletedNCT01463748

Effects of Graptopetalum Paraguayense E. Walther on the Oxidative Stress, Antioxidant Enzyme Activity and Inflammation in Subjects With Metabolic Syndrome

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Chung Shan Medical University · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Metabolic syndrome (MS) is a significant risk factor of cardiovascular disease. The purposes of this study are going to investigate the effects of Graptopetalum paraguayense E. Walther on the oxidative stress, antioxidant enzyme activity and inflammation in subjects with metabolic syndromerelation. The investigators will recruit MS patients(n=50)and the inclusion criteria of MS are according to the Bureau of Health Promotion, Department of Health in Taiwan (2007). The MS subjects are randomly assigned to placebo(n=25) and Graptopetalum paraguayense E. Walther supplements(n=25)groups. Hopefully, the results of this study could provide the information of Graptopetalum paraguayense E. Walther supplements to what has been know in MS subjects.

Conditions

Interventions

TypeNameDescription
OTHERGraptopetalum paraguayense E. WaltherGraptopetalum paraguayense E. Walther
OTHERPlacebostarch

Timeline

Start date
2011-07-01
Primary completion
2013-04-01
First posted
2011-11-02
Last updated
2013-07-03

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01463748. Inclusion in this directory is not an endorsement.